KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacific Biosciences Of California (PACB) Amortizatization of Intangibles (2018 - 2025)

Pacific Biosciences Of California (PACB) has 8 years of Amortizatization of Intangibles data on record, last reported at $1.0 million in Q4 2025.

  • For Q4 2025, Amortizatization of Intangibles rose 112.14% year-over-year to $1.0 million; the TTM value through Dec 2025 reached $369.4 million, up 2936.97%, while the annual FY2025 figure was $369.4 million, 2936.97% up from the prior year.
  • Amortizatization of Intangibles reached $1.0 million in Q4 2025 per PACB's latest filing, down from $366.3 million in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $366.3 million in Q3 2025 and bottomed at -$8.4 million in Q4 2024.
  • Average Amortizatization of Intangibles over 5 years is $19.7 million, with a median of $1.1 million recorded in 2025.
  • Peak YoY movement for Amortizatization of Intangibles: crashed 651.85% in 2022, then surged 5245.4% in 2025.
  • A 5-year view of Amortizatization of Intangibles shows it stood at $1.6 million in 2021, then increased by 23.72% to $2.0 million in 2022, then soared by 67.56% to $3.3 million in 2023, then plummeted by 352.73% to -$8.4 million in 2024, then surged by 112.14% to $1.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Amortizatization of Intangibles were $1.0 million in Q4 2025, $366.3 million in Q3 2025, and $904000.0 in Q2 2025.